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Background: The core question of the study was whether adequately achieved HD affected the sexual dysfunction
in women on hemodialysis (HD) with chronic renal failure (CRF).
Methods: Thirty-seven female patients on HD, including 18 women with adequate HD and 19 women with
non-adequate HD, and 36 healthy controls were included in this study. Demographic and clinical variables,
including the sexual hormones estradiol and testosterone, were recorded. Sexual function was assessed according
to the Female Sexual Function Index (FSFI) and results were compared between groups. Adequate HD was defined
as an average urea clearance of over 1.3 (Kt/V) over three consecutive months.
Results: All domains of the FSFI questionnaire, with the exception of satisfaction, were higher in the control group
than in the HD group. In comparing the adequate and non-adequate HD groups, there was no difference in any of
the six domains of the FSDI questionnaire. Among the clinical variables, the number of menopausal women was
higher in the HD group than in the control group (P = 0.023). Estradiol and testosterone levels were higher in the
control group than in the HD group (P = 0.003, 0.027, respectively). The number of menopausal women and
estradiol and testosterone levels showed no differences between the adequate and non-adequate HD groups.
Correlation analysis between Kt/V and FSFI showed no significant relationship, but estrogen did show a significant
relationship with FSFI (correlation coefficient = 0.399, P = 0.001).
Conclusions: HD adequacy alone does not have a significant impact on sexual dysfunction. Other treatments
options should be considered to treat sexual dysfunction in women with CRF.
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Female sexual dysfunction is common in women experi-
encing chronic renal failure (CRF) and is estimated to
occur at a rate of 60-70% despite the use of dialysis [1,2].
Hemodialysis (HD) is the most commonly used option
for dialysis, and often patients on HD have no choice
but to continue HD until they undergo a kidney trans-
plant (KT). Although there have been many reports re-
garding the improvement of sexual dysfunction after
KT [3,4], those outcomes are not consistent [5,6], and* Correspondence: yssong@schmc.ac.kr
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stated.moreover, from the patients’ perspective, the chance
for a KT is not likely.
In HD patients, adequate HD is important because it
enables the patient to live clinically asymptomatic and
be reasonably active and to maintain correction of the
altered metabolic and homeostatic components secondary
to the loss of the kidney function [7]. Ultimately, adequacy
of HD is related to reduced morbidity and mortality asso-
ciated with CRF [7].
Urea clearance (Kt/V) is a fractional clearance and repre-
sents HD adequacy [8]. However, few studies have investi-
gated whether HD adequacy can improve sexual function in
women with CRF. The aim of this study was to assess the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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with CRF and on HD.Methods
Study sample
From March 2008 to February 2011, a total of 37 con-
secutive married women with CRF who were on HD
were eligible and willing to participate in the study.
Healthy female volunteers (n = 36) from the health
promotion center at Soonchunhyang University Hospital
were included as controls.
Approval for this study was obtained from the Internal
Review Board at Soonchunhyang University Hospital.
The HD group was composed of patients receiving HD
treatment three times a week for 4 hours at one dialysis
procedure for at least 6 months at the HD center at
Soonchunhyang University Hospital.
The eligibility criteria for inclusion were: between the
ages of 18 and 60 years, female gender, married, sexually
active, no psychiatric disease including depression in the
previous 6 months, and the intellectual and mental
capacity to understand and answer the questionnaire.
Exclusion criteria were having undergone surgical meno-
pause, having undergone pelvic surgery including hyster-
ectomy, clinical depression or other major psychiatric
disease and having used hormonal replacement therapy
within the past 5 years. A total of 37 patients were included
in this study (Figure 1).Figure 1 Patient deposition.Clinical investigation
All patients and controls provided informed consent and
underwent detailed clinical examination including testing
hemoglobin, testosterone and estradiol levels, and re-
cording of urea clearance (Kt/V).
To limit the influence of fluctuations in plasma hormone
levels, blood samples were always drawn at the same time
of day (08:00 to 10:00 hours).
Methodology
This was a cross-sectional study. A single investigator
conducted face-to-face interviews with all study participants
using a structured questionnaire.
FSFI questionnaire
To obtain sexual function assessments, the patients were
asked to answer the Female Sexual Function Index (FSFI)
questionnaire after undergoing HD treatment. The FSFI is
an instrument used for the assessment of sexual function
and consists of 19 questions [9,10].
The FSFI has been validated based on the DSM IV
diagnoses of desire disorder, arousal disorder, and orgasmic
dysfunction, and is intended for patients that have been
sexually active in the previous four weeks [9,10]. The FSFI
been previously validated in the Korean language and in
the Korean population [11]. The questions are grouped
and scored for domains of desire (two questions), arousal
(four questions), lubrication (four questions), orgasm
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(three questions). Each domain is scored on a scale of 0 to
6, with higher scores indicating better function for each
domain. A domain score of zero indicates that the women
reported no sexual activity during the previous month and
the full score ranges from 2 to 36. The individual domain
scores are totaled and multiplied by a predetermined
factor to weigh each domain equally.
Assessment of urea clearance (Kt/V)
Urea clearance (Kt/V) is a fractional clearance and is
indicative of HD adequacy. [8] Kt/V is calculated using
the following natural logarithm formula: Kt/V = − Ln
(R - 0.008 × t) + (4 – 3.5 × R) × UF/W, where Ln is the
natural logarithm, R is the ratio between post-dialysis
blood urea nitrogen (BUN) and pre-dialysis BUN, t is the
dialysis session length in hours, UF is the ultrafiltration
volume in liters, and W is the patient’s post-dialysis weight
in kilograms.
Definition of adequate HD
Adequate HD was defined as over 1.3 (Kt/V) average
urea clearance over three consecutive months. The Kidney
Disease Outcomes Quality Initiative (KDOQI) guidelines
(2006) recommend that the Kt/V dose targets are 1.4
with a 1.2 minimum, and the Renal Association Clinical
Practice guidelines recommend a single pool Kt/V of
greater than 1.3.
Statistical analyses
The Kolmogorov-Smirnov test was used to verify the
normality of the distribution of continuous variables.
Nonparametric comparison tests were used for variables
evaluated as not normally distributed. Scores from the
FSFI showed a nonparametric distribution; therefore, the
mean value with standard deviation and the median value
were used together as appropriate to describe statistics.
Differences between groups were determined using the
Kruskal-Wallis test and the Mann–Whitney test as appro-
priate. Spearmann’s correlation test was used to investigate
the association between Kt/V and sexual functional scores.
All statistics were two-tailed and a P value < 0.05 was
considered significant. All calculations were performed
using SPSS version 18.0 (SPSS, Chicargo, Ill., USA).
Results
Baseline analysis among the adequate HD, non-adequate
HD, and normal control groups
There were no differences in age and height between the
control and patient groups. Body weight and body mass
index were significantly lower in the CRF patient group.
The underlying etiologies of renal failure were chronic
glomerulonephritis (n = 6), diabetic nephropathy (n = 12),
hypertensive nephropathy (n = 6), adult polycystic kidney(n = 1) and other etiologies (n = 11). The mean duration of
HD was 8.1 years.
Demographic variables did not differ, with the exception
of body mass index, which was higher in the control
groups. The rate of menopause was significantly higher
in the HD groups, and testosterone and estradiol showed
higher levels in the control groups. The average single–pool
Kt/V in the adequate and non-adequate HD groups was
1.47 ± 0.11 and 1.14 ± 0.05, respectively (Table 1).
Comparative analysis of FSFI scores among the adequate
HD, non-adequate HD, and normal control groups
When comparing the FSFI scores in the control and
study groups, all domain scores except ‘satisfaction’,
namely ‘desire’, ‘arousal’, ‘lubrication’, ‘orgasm’, ‘pain’ and
‘total’, were significantly lower in the HD groups than
the scores of the control groups. The adequate and non-
adequate groups did not differ in any of the domains or
total FSFI (Table 2).
Correlation analysis between Kt/V and FSFI scores
Spearman’s correlation test was performed to evaluate the
associations among the FSFI questionnaire and Kt/V.
The correlation analysis showed no significant relationship
between FSFI and Kt/V (Table 3).
Correlation analysis between other factors and FSFI scores
Age, duration of dialysis, body mass index and testosterone
showed no significant correlation with FSFI scores.
Estrogen showed a significant correlation with all FSFI
domains: ‘desire’ (P < 0.001), ‘arousal’ (P < 0.001), ‘lubrication’
(P < 0.001), ‘orgasm’ (P < 0.001), ‘satisfaction’ (P= 0.047), ‘pain’
(P= 0.003), and ‘total FSFI’ (P= 0.001).
Discussion
Female patients with CRF often suffer from sexual dysfunc-
tion [1,4]. Sexual dysfunction in women with CRF is largely
due to loss of sexual interest, difficulties with arousal and
reaching orgasm, reduced libido and lubrication, and pain
during intercourse [1,12,13].
Considering that there are no other treatment options
except KT, maintaining HD is an important treatment
strategy for patients with CRF. HD adequacy is directly
related to a patient’s well–being, including physical ac-
tivity, and is directly related to mortality and morbidity
[7]. Considering there is no standard protocol for treat-
ing sexual dysfunction in women with CRF on HD, one
important motivation for this study arose from the need
to investigate the impact of HD adequacy on female
sexual dysfunction.
Kt/V, urea fractional clearance, is a standard method
to assess HD adequacy. This kinetic model is a clear was
of determining adequacy [8]. There have been few reports
regarding the role of Kt/V in female sexual dysfunction in
Table 1 Patient characteristics
Controls (n = 36) Adequate HD (n = 18) Non-adequate HD (n = 19) P value
Age (years) 48.19 ± 6.94 47.89 ± 6.82 47.53 ± 6.39 0.671
Height (cm) 155.65 ± 5.46 155.61 ± 4.07 155.741 ± 4.50 0.978
Weight [24] 58.84 ± 7.27 56.11 ± 9.46 54.18 ± 5.76 0.052
Body mass index (kg/m2) 24.31 ± 3.02 23.08 ± 3.26† 22.37 ± 2.60‡ 0.036*
Educational level 0.321
Middle school or less 8 (22.2%) 3 (16.6%) 3 (15.7%)
High school 10 (27.7%) 10 (55.5%) 9 (47.3%)
College or more 18 (50.0%) 5 (27.7%) 7 (36.8%)
Monthly income (won) 0.072
<1 million 7 (19.4%) 6 (33.3%) 7 (36.8%)
1-3 million 19 (52.7%) 7 (38.8%) 8 (42.1%)
>3 million 10 (27.7%) 5 (27.7%) 4 (21.0%)
Menopause (%) 10 (27.7%) 13 (66.5%) 12 (63.1%) 0.023**
Hematocrit (%) 29.8 28.1 28.3 0.057
Testosterone (ng/ml) 1.25 ± 2.25 0.45 ± 0.06† 0.26 ± 0.08‡ 0.027*
Estradiol (pg/ml) 80.93 ± 77.24 27.55 ± 20.82† 34.68 ± 55.69‡ 0.003*
Duration of HD (years) 7.4 ± 6.99 8.5 ± 3.99 0.781
Onset of CRF 10.5 ± 5.29 11.5 ± 6.72 0.574
Average single-pool Kt/V 1.47 ± 0.11 1.14 ± 0.05 0.021***
HD, hemodialysis, CRF, chronic renal failure. *analyzed by Kruskal-Wallis test; **analyzed by Fisher’s exact test; ***analyzed by Mann Whitney test. †Control versus ad-
equate HD, ‡Control versus non-adequate HD.
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HD adequacy was not related to female sexual dysfunction.
One of the limitations of those studies was the application
of the Kt/V results. Recently, the recommended dose was
increased to a target of 1.4. The KDOQI guidelines (2006)
recommend a Kt/V dose target of 1.4 with a minimum
of 1.2, and the Renal Association Clinical Practice guide-
lines recommend a single pool Kt/V of greater than 1.3.
More importantly, HD adequacy cannot determined by
a single Kt/V, but rather consecutive and consistent target
doses of Kt/V are more important. In our study, ad-
equate HD was defined as an average Kt/V of 1.3 over
three consecutive months.Table 2 Female sexual function index in patients with chronic
FSFI Controls (n = 36) Adequate HD (n
Desire 2.4 ± 0.90, 2.4 1.43 ± 0.68†, 1
Arousal 2.68 ± 1.90, 3.0 1.11 ± 1.71†,
Lubrication 3.30 ± 2.33, 3.9 1.66 ± 2.44†,
Orgasm 2.88 ± 2.11, 3.6 1.48 ± 2.23†,
Satisfaction 3.45 ± 1.66, 4.0 2.06 ± 1.70, 0
Pain 3.37 ± 2.27, 4.0 1.75 ± 2.59†,
Total 18.11 ± 10.24, 22.0 9.52 ± 10.64†,
Values are expressed as mean ± SD, median value.
HD, hemodialysis; FSFI, Female Sexual Function Index. *analyzed by Kruskal-Wallis te
†Control versus adequate HD, ‡Control versus non-adequate HD.Although our study did not find an association between
HD adequacy and female sexual dysfunction, this is the
first study to assess the relation between sexual dysfunc-
tion and HD adequacy as measured using the consecutive
method in women with CRF.
We reported in a previous study that the score of all
domains of the FSFI questionnaire, ‘desire’, ‘arousal’,
‘lubrication’, ‘orgasm’, ‘satisfaction’ and ‘pain’, were signifi-
cantly lower in the patient group than in the control
group [16]. However, it is not clear that HD adequacy
is related to sexual dysfunction. Our results show that HD
adequacy alone does not restore sexual dysfunction in
women with CRF. This is in agreement with a reportrenal failure who are on hemodiaysis
= 18) Non-adequate HD (n = 19) P value*
.2 2.08 ± 2.47‡, 1.2 <0.001
0 0.93 ± 1.87‡, 0 0.001
0 1.16 ± 2.33‡, 0 0.004
0 0.96 ± 1.93‡, 0 0.004
.8 2.88 ± 1.79, 4.0 0.052
0 1.20 ± 2.40‡, 0 0.011
2 8.76 ± 9.52‡, 5.2 0.003
st.
Table 3 Correlation coefficients between average
single-pool Kt/V and female sexual function index score








FSFI, Female Sexual Function Index. *analyzed by Spearman’s correlation test.
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treatment [17].
As the genesis of sexual dysfunction is multifactorial
in CRF patients, one aspect of HD adequacy alone was
insufficient for explaining sexual dysfunction. It is believed
that the lack of estradiol-stimulated cyclic LH secretion in
women on dialysis leads to ovarian failure, which is pre-
sumed to be the primary cause of infertility [13,15,18,19].
Our results showed that levels of testosterone and estra-
diol were significantly decreased in the patient group.
Moreover, estradiol showed a significant relationship with
the scores in all domains of the FSFI. A previous study
demonstrated that hormone replacement therapy allows
sustained physiological serum estradiol concentrations in
women with estrogen deficiency undergoing HD, with an
associated improvement in sexual function [20]. It is sug-
gested that adequate treatment of multiple factors, includ-
ing emotional derangement and sex hormone change, is
also necessary for improvement in sexual function in fe-
male CRF patients. Among them, hormonal replacement
therapy (HRT) could be a promising treatment option. To
date, only 17% of dialysis women had ever been treated
with HRT and even less (6%) were currently on such ther-
apy [21]. The benefits of HRT in premenopausal women
on dialysis with estrogen deficiency treated with transder-
mal HRT have been reported to show a sustained increase
in estrogen and recovery of menstruation [20].
This study had some limitations. First, our patient
population was quite small. Generally, the participation
rate in sex research is very low and the degree of con-
servatism in sexual attitudes was very high in those
who refused participation. Second, the patients repre-
sented only a small geographic area, which limits the
generalization of our findings. Third, we did not inves-
tigate the depression quantification by questionnaire.
Although we excluded those patients with depression,
concurrent and subclinical depression could be determined
through a questionnaire. However, the diagnostic cut-off
values of the Beck depression inventory, which is one of
most commonly used questionnaires to assess depression,
is not consistent between the DSM-IV criteria and Koreanvalidation form [22]. Therefore, the Beck depression
inventory was not applied in our study. Fourth, we have not
investigated other factors such as vascular abnormalities,
medications, family interactions, and personal and social
characteristics. Lastly, this study was not a prospective
study. A prospective study of CRF patients is difficult as
symptom onset is diverse, and indication and the method
of dialysis differ according to each patient’s medical condi-
tion. Further research, including a multi-center prospect-
ive study, is warranted for investigating sexual dysfunction
in females with CRF who are undergoing HD.
Conclusion
In summary, sexual dysfunction was found in women
with CRF who were on HD. HD adequacy alone does not
have an impact on sexual dysfunction. Our results indicate
that new strategies for the treatment of sexual dysfunction
in women with CRF who are on HD are needed.
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